- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
1947
Companies with a Value score of at least 3, ordered by Value score
1947 companies
Spectrum Pharmaceuticals
Market Cap: €209.9m
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.
NTR
€0.93
7D
0.5%
1Y
11.6%
Trajan Group Holdings
Market Cap: AU$112.1m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.74
7D
-1.3%
1Y
-41.3%
Cosmo Pharmaceuticals
Market Cap: CHF 1.1b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPNZ
CHF 66.30
7D
2.3%
1Y
-10.9%
Sanofi
Market Cap: €103.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SNW
€85.03
7D
7.2%
1Y
-17.0%
Regeneron Pharmaceuticals
Market Cap: €58.3b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
RGO
€473.20
7D
-1.2%
1Y
-49.7%
Grand Pharmaceutical Group
Market Cap: €29.8b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
MX6A
€0.91
7D
1.1%
1Y
59.6%
Sanofi
Market Cap: €103.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
1SAN
€85.02
7D
6.8%
1Y
-16.8%
Royalty Pharma
Market Cap: US$20.6b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$36.32
7D
1.5%
1Y
28.6%
Regeneron Pharmaceuticals
Market Cap: €58.3b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
1REGN
€522.20
7D
6.6%
1Y
-44.7%
Amphastar Pharmaceuticals
Market Cap: US$1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$26.99
7D
0.4%
1Y
-42.0%
Royalty Pharma
Market Cap: €20.6b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPD
€30.10
7D
-1.2%
1Y
19.5%
Hikma Pharmaceuticals
Market Cap: €4.0b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
H5P
€20.80
7D
13.7%
1Y
-8.0%
Sanofi
Market Cap: €103.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
0O59
€84.70
7D
6.5%
1Y
-17.5%
Sanofi
Market Cap: €103.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SANP
€81.56
7D
2.3%
1Y
-21.3%
Regeneron Pharmaceuticals
Market Cap: US$58.3b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$599.94
7D
4.0%
1Y
-42.3%
CorMedix
Market Cap: US$907.8m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$11.05
7D
-1.7%
1Y
33.6%
Sanofi
Market Cap: €103.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€85.18
7D
7.1%
1Y
-16.6%
Catalyst Pharmaceuticals
Market Cap: US$2.4b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$20.91
7D
6.1%
1Y
4.6%
Hikma Pharmaceuticals
Market Cap: UK£4.0b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£17.95
7D
11.3%
1Y
-6.1%
Sanofi
Market Cap: €103.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SNW
€84.94
7D
7.1%
1Y
-16.8%
Jazz Pharmaceuticals
Market Cap: US$8.0b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$136.90
7D
5.6%
1Y
24.8%
Evolus
Market Cap: €397.2m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EVL
€5.35
7D
0%
1Y
-65.3%
Beijing Tongrentang
Market Cap: CN¥46.7b
Engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally.
600085
CN¥34.02
7D
-1.2%
1Y
-19.1%
Yunnan Baiyao GroupLtd
Market Cap: CN¥101.3b
Engages in the pharmaceutical business in China.
000538
CN¥56.75
7D
-1.6%
1Y
-7.0%
Genomma Lab Internacional. de
Market Cap: €18.8b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
GEKA
€0.87
7D
-3.3%
1Y
-13.9%
Dong-A Socio Holdings
Market Cap: ₩738.2b
Engages in the pharmaceutical business in South Korea.
A000640
₩112,800.00
7D
-2.7%
1Y
2.2%
Haleon
Market Cap: €29.7b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
H6D0
€3.90
7D
3.8%
1Y
-16.4%
Regeneron Pharmaceuticals
Market Cap: US$62.2b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
0R2M
US$606.45
7D
9.0%
1Y
-40.4%
Hugel
Market Cap: ₩3.2t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩285,500.00
7D
-3.4%
1Y
18.2%
Wuhan Keqian BiologyLtd
Market Cap: CN¥8.2b
Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.
688526
CN¥17.72
7D
0.3%
1Y
18.2%
Dong-E-E-JiaoLtd
Market Cap: CN¥30.5b
Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.
000423
CN¥47.40
7D
-1.5%
1Y
-23.2%
Yunnan Baiyao GroupLtd
Market Cap: CN¥101.3b
Engages in the pharmaceutical business in China.
000538
CN¥56.75
7D
-1.6%
1Y
-7.0%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Market Cap: €1.8t
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
RIG2
€26.08
7D
3.7%
1Y
-5.0%
Decibel Cannabis
Market Cap: US$77.9m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DBCC.F
US$0.10
7D
6.8%
1Y
145.6%
Cosmo Pharmaceuticals
Market Cap: CHF 1.1b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 66.10
7D
1.7%
1Y
-11.2%
Hikma Pharmaceuticals
Market Cap: UK£4.0b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIKL
UK£17.95
7D
11.0%
1Y
-5.8%